Clinical trial

Diuretics and Volume Overload in Early CKD

NCT05171686

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-02-01

PhasePHASE4

Study timeline

Study start (actual)2023-02-01Date precision: day

Registry last updated2026-09-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Kidney Diseaseunresolved

Hypertensionunresolved

Interventions

Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)DRUG

Sponsors & collaborators

VA Office of Research and Developmentlead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05171686 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.